6 completed, 1 not yet recruiting. 5 Phase 1, 1 Not applicable, 1 Phase 2.
By phase and status
Follow Health Volunteers: new trials by email Literature Review of Health Volunteers trials Research Report on Health Volunteers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers
68Ga-ACC-DE/68Ga-FASN-DE/68Ga-ACLY-DE PET/CT - Melanoma (Skin Cancer), Health Volunteers | Not applicable | Not yet recruiting | Xijing Hospital | 15 | 2025-08-15 | 2025-08-11 |
A Study to Assess Tolerability of the Trivalent Recombinant Vaccine in Individuals Aged 18 and Older Using the Vaccinees Perception of Injection Questionnaire
Trivalent Recombinant Influenza Vaccine - Influenza Immunization, Health Volunteers | | Completed | Sanofi | 1007 | 2024-11-18 | 2026-04-07 |
Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects
CTP-543, Fluconazole - Health Volunteers | Phase 1 | Completed | Concert Pharmaceuticals | 18 | 2022-07-11 | 2022-08-30 |
Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects
Midazolam, CTP-543 - Health Volunteers | Phase 1 | Completed | Concert Pharmaceuticals | 20 | 2022-06-21 | 2022-07-20 |
Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers
CTP-543 - Health Volunteers | Phase 1 | Completed | Concert Pharmaceuticals | 16 | 2022-06-14 | 2022-07-20 |
A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults
ABX464 150mg, ABX464 50mg - HIV Infections, Health Volunteers | Phase 1 / Phase 2 | Completed | Abivax S.A. | 36 | 2017-03-27 | 2023-03-31 |
An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male Subjects
Betrixaban single oral dose - Health Volunteers | Phase 1 | Completed | Portola Pharmaceuticals | 5 | 2007-09-01 | 2023-08-04 |
Narrower conditions
HIV Infections (1) · Influenza, Human (1) · Melanoma (1)
Broader conditions
Infections (2) · RNA Virus Infections (2) · Virus Diseases (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Lentivirus Infections (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1)
Interventions
ABX464 (1) · Fluconazole (1) · Midazolam (1)
Sponsors
Concert Pharmaceuticals (3) · Abivax S.A. (1) · Portola Pharmaceuticals (1) · Sanofi (1) · Xijing Hospital (1)
Countries
United States (4) · Spain (1)
Results publications
PMID 34436569